Pulse-based Foods for Alleviation of Negative Consequences of Sedentary Behaviour

October 19, 2021 updated by: Phil Chilibeck, University of Saskatchewan

Development of Pre-Packaged Pulse-Based Meals to Ameliorate the Negative Health Consequences of Sedentary Behavior

The hypothesis is that consumption of pulse-based foods (i.e. containing chickpeas, lentils, and split peas) during the workday will improve insulin sensitivity, glucose tolerance, blood lipids, body composition, and blood pressure in sedentary office workers.One-hundred office workers from a university campus will participate in a cross-over study where they will be randomized (i.e. assigned by chance) to receive pre-packaged pulse-based lunches and snacks to replace their usual lunches/snacks during the work day OR to continue consuming their usual diets for two months. After the first dietary intervention, they will undergo a 1-month "wash-out" and then participate in two months of the opposite dietary intervention. The main outcome to be assessed is change in glucose and insulin (i.e. blood sugar control) determined during an oral glucose tolerance test. Secondary outcomes include changes in body composition, lipids, and blood pressure.

During the pulse-based diet phases, participants will be supplied with a ready-to-eat lunch and two snacks to eat during each workday. These will contain a total of 150g/d dry weight (250g/d wet weight) pulses

Study Overview

Detailed Description

Sedentary behaviour has been deemed the "new smoking" based on multiple and potent negative impacts on health. Moreover, sedentary behaviour is a strong predictor of type 2 diabetes risk and cardiovascular disease. Previous studies have show that pulse-based meals derived from lentils, beans, chickpeas, and peas are effective for alleviating risk factors associated with diabetes and cardiovascular disease in clinical populations including older adults, overweight and obese individuals, and women with polycystic ovary syndrome; however, to date, there have been no nutrition-based interventions for alleviating risk factors for diabetes specifically targeting office workers exposed to long periods of sitting. Although people are aware of the health benefits of pulses, a major barrier to increased consumption continues to be a lack of knowledge on how to prepare pulse-based meals. This proposed study is designed to overcome this barrier. The main goal of this research study is to determine whether improvements in cardio-metabolic health can be realized by giving people pulse-based lunches and snacks to replace their regular workplace lunches and snacks. In this randomized controlled trial, 100 office workers from the University of Saskatchewan will participate in a cross-over study where they will be randomized into one of two diets for 2 months: Receive pre-packaged pulse-based lunches and snacks to replace their usual lunches/snacks during the work day OR to continue consuming their usual diets for two months. After a one-month washout, they will cross-over to the other condition. The primary outcome measure, Matsuda Index (determined by blood glucose and insulin responses to an oral glucose tolerance test), will be assessed before each diet phase and at the end (i.e. two months) of each diet phase. Secondary outcome measures (body composition, waist girth, lipids, blood pressure will also be assessed.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Saskatchewan
      • Saskatoon, Saskatchewan, Canada, S7N5B2
        • College of Kinesiology, University of Saskatchewan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men and Women
  • 18y or older
  • Engaged in >5 hours per day sitting

Exclusion Criteria:

  • Diagnosed with diabetes
  • taking glucose or lipid-lowering medication
  • Regular consumers of pulses (1.5 cups (250g) or greater of pulses per week)
  • Engaged in 60 minutes or greater of physical activity per day

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Low Glycemic Index
Pulse-based diet
Low Glycemic Index
Active Comparator: Moderate Glycemic Index
Regular diet
Moderate Glycemic Index

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insulin sensitivity
Time Frame: Change from baseline to 8 weeks
Matsuda Index determined by glucose and insulin response to oral glucose tolerance test
Change from baseline to 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glucose area under the curve
Time Frame: Change from baseline to 8 weeks
Glucose area under the curve from a 2-hour oral glucose tolerance test
Change from baseline to 8 weeks
Insulin area under the curve
Time Frame: Change from baseline to 8 weeks
Insulin area under the curve from a 2-hour oral glucose tolerance test
Change from baseline to 8 weeks
Fasting glucose
Time Frame: Change from baseline to 8 weeks
Fasting glucose
Change from baseline to 8 weeks
Fasting insulin
Time Frame: Change from baseline to 8 weeks
Fasting insulin
Change from baseline to 8 weeks
Low-density lipoprotein cholesterol
Time Frame: Change from baseline to 8 weeks
LDL-C from fasting blood samples
Change from baseline to 8 weeks
High-density lipoprotein cholesterol
Time Frame: Change from baseline to 8 weeks
HDL-C from fasting blood samples
Change from baseline to 8 weeks
Total cholesterol
Time Frame: Change from baseline to 8 weeks.
Total cholesterol from fasting blood samples
Change from baseline to 8 weeks.
Triglycerides
Time Frame: Change from baseline to 8 weeks
Triglycerides from fasting blood samples
Change from baseline to 8 weeks
Waist Girth
Time Frame: Change from baseline to 8 weeks
Waist Girth
Change from baseline to 8 weeks
Fat mass
Time Frame: Change from baseline to 8 weeks
Fat mass from DXA measurements
Change from baseline to 8 weeks
Lean tissue mass
Time Frame: Change from baseline to 8 weeks
Lean tissue mass from DXA measurements
Change from baseline to 8 weeks
Systolic blood pressure
Time Frame: Change from baseline to 8 weeks
Systolic blood pressure measured at rest
Change from baseline to 8 weeks
Diastolic blood pressure
Time Frame: Change from baseline to 8 weeks
Diastolic blood pressure measured at rest
Change from baseline to 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2019

Primary Completion (Actual)

May 15, 2021

Study Completion (Actual)

June 30, 2021

Study Registration Dates

First Submitted

May 6, 2019

First Submitted That Met QC Criteria

May 7, 2019

First Posted (Actual)

May 8, 2019

Study Record Updates

Last Update Posted (Actual)

October 21, 2021

Last Update Submitted That Met QC Criteria

October 19, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 609

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Insulin Sensitivity

Clinical Trials on Pulse-based diet

Subscribe